Skip to main content

Advertisement

SpringerLink
Log in

Sexual and Reproductive Health for Transgender and Gender-Diverse Patients

  • Care for the Transgender Patients (C Ferrando, Section Editor)
  • Published:
Current Obstetrics and Gynecology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This review provides an overview of sexual and reproductive health considerations for transgender and gender-diverse (TGD) patients.

Recent Findings

New evidence is emerging that expands the current knowledge of TGD patient’s health needs and better informs providers to allow for more robust counseling regarding reproductive and sexual options.

Summary

TGD patients have a variety of sexual and reproductive health needs. Fertility preservation (FP), while underutilized, is desired and successful for TGD patients. Developing FP technologies are expanding the options we can offer patients. The effect of hormonal therapy on future fertility does not appear to be significant, but warrants further research given conflicting data. While visibility of TGD patients’ experiences with pregnancy is heightened, little is known regarding long-term pregnancy outcomes in this population. Contraceptive choice for TGD patients should be driven by patient desire to prevent pregnancy and, for patients assigned female at birth (AFAB), suppress menstruation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance, •• Of major importance

  1. Stroumsa D, Roberts EF, Kinnear H, Harris LH. The power and limits of classification—a 32-year-old man with abdominal pain. N. Engl. J. Med. 2019;380(20):1885.

    Article  Google Scholar 

  2. • Qin LA, Estevez SL, Radcliffe E, Shan WW, Rabin JM, Rosenthal DW. Are Obstetrics and Gynecology Residents Equipped to Care for Transgender and Gender Nonconforming Patients? A National Survey Study. Transgender Health. 2021;6(4):194–200. Largest study investigating obstetrician and gynecology residents’ comfort with providing care for TGD patients.

  3. • Nahata L, Chen D, Quinn GP, Travis M, Grannis C, Nelson E, Tishelman AC. Reproductive attitudes and behaviors among transgender/nonbinary adolescents. J. Adolesc. Health. 2020;66(3):372–4. A survey of TGD adolescents that demonstrated a lack of desire for counseling on contraceptive options, but acknowledged that these feelings may change with time.

  4. Strang JF, Jarin J, Call D, Clark B, Wallace GL, Anthony LG, Kenworthy L, Gomez-Lobo V. Transgender youth fertility attitudes questionnaire: measure development in nonautistic and autistic transgender youth and their parents. J. Adolesc. Health. 2018;62(2):128–35.

    Article  Google Scholar 

  5. Clark B, Jarin J, Strang J, Call D, Solages M, Gomez-Lobo V. Transgender adolescent attitudes towards their future fertility. J Pediatr Adolesc Gynecol. 2017;30(2):326.

    Article  Google Scholar 

  6. Chen D, Kolbuck VD, Sutter ME, Tishelman AC, Quinn GP, Nahata L. Knowledge, practice behaviors, and perceived barriers to fertility care among providers of transgender healthcare. J. Adolesc. Health. 2019;64(2):226–34.

    Article  Google Scholar 

  7. Chen D, Simons L. Ethical considerations in fertility preservation for transgender youth: A case illustration. Clin. Pract. Pediatr. Psychol. 2018;6(1):93.

    Article  Google Scholar 

  8. Schelble AP, Fisher AR, Jungheim E, Lewis C, Omurtag K. Fertility preservation (FP) referral and follow-up in male-to-female (MTF) and female-to-male (FTM) transgender patients. Fertil. Steril. 2017;108(3):e115–6.

    Article  Google Scholar 

  9. •• Moseson H, Fix L, Hastings J, Stoeffler A, Lunn MR, Flentje A, Lubensky ME, Capriotti MR, Ragosta S, Forsberg H, Obedin-Maliver J. Pregnancy intentions and outcomes among transgender, nonbinary, and gender-diverse people assigned female or intersex at birth in the United States: results from a national, quantitative survey. Int. J. Transgend. Health. 2020;22(1–2):30–41. The largest survey (n=1694) investigating pregnancy outcomes among TGD patients. This larger study showed no difference in intended pregnancy based on prior testosterone use, contrary to previous data published by Light et al.

  10. Riggs DW, Bartholomaeus C. Fertility preservation decision making amongst Australian transgender and non-binary adults. Reprod. Health. 2018;15(1):1.

    Article  Google Scholar 

  11. Fein LA, Zaw C, Wong A, Jhaveri V, Gerkowicz SA, Potter J. Reproductive Health Care Knowledge, Needs, and Access Among Transgender Men: A Mixed Methods Study [6R]. Obstet. Gynecol. 2019;133:192S-S193.

    Article  Google Scholar 

  12. •• Light A, Wang LF, Zeymo A, Gomez-Lobo V. Family planning and contraception use in transgender men. Contraception. 2018;98(4):266–9. One of the largest studies investigating contraception use and pregnancy among transgender men. This survey highlighted concerns around the use of gender affirming therapy and effect on future parenting. Patients who had never take testosterone were three times more likely to conceive than those who had. No patients conceived while taking testosterone consistently, which is contrary to previously reported surveys that showed a high percentage of patients who became pregnant while amenorrheic from testosterone. Additionally, this survey is one of the few surveys looking at abortion prevalence in the TGD population.

  13. Morong JJ, Hinz E. Fertility preservation in transgender and gender non-conforming adults [21A]. Obstet. Gynecol. 2020;135:14S.

    Article  Google Scholar 

  14. Tornello SL, Bos H. Parenting intentions among transgender individuals. LGBT Health. 2017;4(2):115–20.

    Article  Google Scholar 

  15. Auer MK, Fuss J, Nieder TO, Briken P, Biedermann SV, Stalla GK, Beckmann MW, Hildebrandt T. Desire to have children among transgender people in Germany: a cross-sectional multi-center study. J. Sex Med. 2018;15(5):757–67.

    Article  Google Scholar 

  16. Linde R, Doelle GC, Alexander N, Kirchner F, Vale W, Rivier J, Rabin D. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. N. Engl. J. Med. 1981;305(12):663–7.

    Article  CAS  Google Scholar 

  17. Martin CE, Lewis C, Omurtag K. Successful oocyte cryopreservation using letrozole as an adjunct to stimulation in a transgender adolescent after GnRH agonist suppression. Fertil. Steril. 2021;116(2):522–7.

    Article  CAS  Google Scholar 

  18. Mattawanon N, Spencer JB, Schirmer DA, Tangpricha V. Fertility preservation options in transgender people: a review. Rev. Endocr. Metab. Disord. 2018;19(3):231–42.

    Article  Google Scholar 

  19. Rothenberg SS, Witchel SF, Menke MN. Oocyte cryopreservation in a transgender male adolescent. N. Engl. J. Med. 2019;380(9):886–7.

    Article  Google Scholar 

  20. Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, Fraser L, Green J, Knudson G, Meyer WJ, Monstrey S. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int. J. Transgend. 2012;13(4):165–232.

    Article  Google Scholar 

  21. Adeleye AJ, Reid G, Kao CN, Mok-Lin E, Smith JF. Semen parameters among transgender women with a history of hormonal treatment. Urology. 2019;124:136–41.

    Article  Google Scholar 

  22. Jindarak S, Nilprapha K, Atikankul T, Angspatt A, Pungrasmi P, Iamphongsai S, Promniyom P, Suwajo P, Selvaggi G, Tiewtranon P. Spermatogenesis abnormalities following hormonal therapy in transwomen. Biomed Res Int. 2018 Apr;2:2018.

  23. Borrás A, Manau MD, Fabregues F, Casals G, Saco A, Halperin I, Mora M, Goday A, Barral Y, Carmona F. Endocrinological and ovarian histological investigations in assigned female at birth transgender people undergoing testosterone therapy. Reprod. Biomed. Online. 2021;43(2):289–97.

    Article  Google Scholar 

  24. • De Roo C, Tilleman K, Vercruysse C, Declercq H, T’Sjoen G, Weyers S, De Sutter P. Texture profile analysis reveals a stiffer ovarian cortex after testosterone therapy: a pilot study. J. Assist. Reprod. Genet. 2019;36(9):1837–43. Analysis of ovarian changes after testosterone use highlighting a stiffer ovarian cortex, similar to that seen in polycystic ovarian syndrome.

  25. Khalifa MA, Toyama A, Klein ME, Santiago V. Histologic features of hysterectomy specimens from female-male transgender individuals. Int. J. Gynecol. Pathol. 2019;38(6):520–7.

    Article  Google Scholar 

  26. Kinnear HM, Constance ES, David A, Marsh EE, Padmanabhan V, Shikanov A, Moravek MB. A mouse model to investigate the impact of testosterone therapy on reproduction in transgender men. Hum. Reprod. 2019;34(10):2009–17.

    Article  CAS  Google Scholar 

  27. • Grimstad FW, Fowler KG, New EP, Ferrando CA, Pollard RR, Chapman G, Gray M, Lobo VG. Ovarian histopathology in transmasculine persons on testosterone: a multicenter case series. J. Sexual Med. 2020;17(9):1807–18. Analysis of ovarian changes after testosterone that showed benign pathology, tempering concerns for malignant potential and need for gonadectomy prior to administration of testosterone.

  28. Yaish I, Tordjman K, Amir H, Malinger G, Salemnick Y, Shefer G, Serebro M, Azem F, Golani N, Sofer Y, Stern N. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment. Hum. Reprod. 2021;36(10):2753–60.

    Article  CAS  Google Scholar 

  29. •• Lierman S, Tilleman K, Braeckmans K, Peynshaert K, Weyers S, T’Sjoen G, De Sutter P. Fertility preservation for trans men: frozen-thawed in vitro matured oocytes collected at the time of ovarian tissue processing exhibit normal meiotic spindles. J. Assist. Reprod. Genet. 2017;34(11):1449–56. Study of in vitro maturation of oocytes isolated from transgender men that showed normal spindle structure and meiotic spindles. This supports the feasibility of ovarian tissue cryopreservation. Patients also showed normal markers of ovarian reserve despite testosterone use.

  30. •• Leung A, Sakkas D, Pang S, Thornton K, Resetkova N. Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine. Fertil. Steril. 2019;112(5):858–65. Cohort study examining oocyte retrieval after ART between TGD patients and cisgender patients. TGD patients had high yield of oocytes despite past testosterone therapy. Additionally, those who underwent fresh and frozen embryo transfer resulted in live births.

  31. •• Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet. Gynecol. 2014;124(6):1120–7. One of the largest surveys investigating pregnancy outcomes among transgender men. An important finding was that 20% of patients conceived while amenorrheic from testosterone. Additionally, there was no difference in pregnancy outcomes and complications between those who had been on testosterone prior and those who had not.

  32. Armuand G, Dhejne C, Olofsson JI, Rodriguez-Wallberg KA. Transgender men’s experiences of fertility preservation: a qualitative study. Hum. Reprod. 2017;32(2):383–90.

    Article  CAS  Google Scholar 

  33. Stark BA, Mok-Lin E. Fertility preservation in transgender men without discontinuation of testosterone. F&S Reports. 2022 Feb 9.

  34. • Greenwald P, Dubois B, Lekovich J, Pang JH, Safer J. Successful In Vitro Fertilization in a Cisgender Female Carrier Using Oocytes Retrieved From a Transgender Man Maintained on Testosterone. AACE Clin. Case Rep. 2021. The only case study investigating ART in patients currently maintained on testosterone. These promising results warrant further research to determine if testosterone needs to be stopped during ART.

  35. Ainsworth AJ, Allyse M, Khan Z. Fertility preservation for transgender individuals: a review. Mayo Clin. Proc. 2020;95(4):784–792. Elsevier.

  36. Sterling J, Garcia MM. Fertility preservation options for transgender individuals. Transl Androl Urol. 2020 Mar;9(Suppl 2):S215.

  37. Johnson EK, Finlayson C. Preservation of fertility potential for gender and sex diverse individuals. Transgender Health. 2016;1(1):41–4.

    Article  Google Scholar 

  38. Donnez J, Dolmans MM. Fertility preservation in women. N. Engl. J. Med. 2017;377(17):1657–65.

    Article  Google Scholar 

  39. Practice Committee of the American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil. Steril. 2019;112(6):1022–33.

  40. Mehringer J, Dowshen NL. Sexual and reproductive health considerations among transgender and gender-diverse youth. Curr. Problems Pediatr. Adolesc. Health Care. 2019;49(9):100684.

  41. • Adeleye AJ, Stark BA, Jalalian L, Mok-Lin E, Smith JF. Evidence of Spermatogenesis in the Presence of Hypothalamic Suppression and Low Testosterone in an Adolescent Transgender Female: A Case Report. Transgender Health. 2021. This is the only published case report on a patient undergoing successful sperm cryopreservation without pausing feminizing therapy or undergoing natal puberty.

  42. García A, Herrero MB, Holzer H, Tulandi T, Chan P. Assisted reproductive outcomes of male cancer survivors. J. Cancer. Surviv. 2015;9(2):208–14.

    Article  Google Scholar 

  43. • Goldman RH, Kaser DJ, Missmer SA, Farland LV, Ashby RK, Ginsburg ES. Fertility treatment for the transgender community: a public opinion study. J. Assist. Reprod. Genet. 2017;34(11):1457–67. This large national opinion survey showed the majority of people believe that providers should help TGD patients with their parenting intentions.

  44. • Nahata L, Tishelman AC, Caltabellotta NM, Quinn GP. Low fertility preservation utilization among transgender youth. J. Adolesc. Health. 2017;61(1):40–4. Largest survey of TGD adolescents who underwent fertility preservation (FP) counseling and their subsequent utilization of FP options.

  45. • Chen D, Simons L, Johnson EK, Lockart BA, Finlayson C. Fertility preservation for transgender adolescents. J. Adolesc. Health. 2017;61(1):120–3. A retrospective chart review that highlights the low percentage of patients who underwent a fertility preservation consultation.

  46. •• Chen D, Matson M, Macapagal K, Johnson EK, Rosoklija I, Finlayson C, Fisher CB, Mustanski B. Attitudes toward fertility and reproductive health among transgender and gender-nonconforming adolescents. J. Adolesc. Health. 2018;63(1):62–8. Largest survey investigating attitudes toward parenting and fertility preservation among TGD adolescents. This study showed a high desire for parenting, both biologic and adoption. Contrary to survey data published by Nahata et al, a significant amount of patients desired counseling on fertility preservation options.

  47. Persky RW, Gruschow SM, Sinaii N, Carlson C, Ginsberg JP, Dowshen NL. Attitudes toward fertility preservation among transgender youth and their parents. J. Adolesc. Health. 2020;67(4):583–9.

    Article  Google Scholar 

  48. Sbragia JD, Vottero B. Experiences of transgender men in seeking gynecological and reproductive health care: a qualitative systematic review. JBI Evidence Synthesis. 2020;18(9):1870–931.

    Article  Google Scholar 

  49. Tishelman AC, Sutter ME, Chen D, Sampson A, Nahata L, Kolbuck VD, Quinn GP. Health care provider perceptions of fertility preservation barriers and challenges with transgender patients and families: qualitative responses to an international survey. J. Assist. Reprod. Genet. 2019;36(3):579–88.

    Article  Google Scholar 

  50. Miller DP. Emergency contraception. Ann Intern Med. 2003 Feb 4;138(3):237–8.

  51. Krempasky C, Harris M, Abern L, Grimstad F. Contraception across the transmasculine spectrum. Am. J. Obstet. Gynecol. 2020;222(2):134–43.

    Article  CAS  Google Scholar 

  52. Carswell JM, Roberts SA. Induction and maintenance of amenorrhea in transmasculine and nonbinary adolescents. Transgender Health. 2017;2(1):195–201.

    Article  Google Scholar 

  53. Grynberg M, Fanchin R, Dubost G, Colau JC, Brémont-Weil C, Frydman R, Ayoubi JM. Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. Reprod. Biomed. Online. 2010;20(4):553–8.

    Article  CAS  Google Scholar 

  54. Schubert FD, Carey JM. Data unclear on pregnancy risk in transmasculine individuals on testosterone. Am. J. Obstet. Gynecol. 2020;222(4):393–4.

    Article  CAS  Google Scholar 

  55. Jones RK, Witwer E, Jerman J. Transgender abortion patients and the provision of transgender-specific care at non-hospital facilities that provide abortions. Contraception: X. 2020;2:100019.

  56. Abern L, Nippita S, Maguire K. Contraceptive use and abortion views among transgender and gender-nonconforming individuals assigned female at birth. Contraception. 2018;98(4):337.

    Article  Google Scholar 

  57. •• Moseson H, Fix L, Ragosta S, Forsberg H, Hastings J, Stoeffler A, Lunn MR, Flentje A, Capriotti MR, Lubensky ME, Obedin-Maliver J. Abortion experiences and preferences of transgender, nonbinary, and gender-diverse people in the United States. Am. J. Obstet. Gynecol. 2021;224(4):376-e1. The largest survey (n=1694) investigating abortion experience among TGD patients. This study showed a preference for medical abortions and highlighted areas to improve quality of abortion care provided to TGD patients.

  58. Hahn M, Sheran N, Weber S, Cohan D, Obedin-Maliver J. Providing patient-centered perinatal care for transgender men and gender-diverse individuals: A collaborative multidisciplinary team approach. Obstet. Gynecol. 2019;134(5):959.

    Article  Google Scholar 

  59. • Oberhelman-Eaton S, Chang A, Gonzalez C, Braith A, Singh RJ, Lteif A. Initiation of Gender-Affirming Testosterone Therapy in a Lactating Transgender Man. J. Hum. Lactation. 2021:08903344211037646. The only published study of testosterone use in chest feeding, excretion in chest milk and the corresponding serum levels in infant. The low levels seen in infant serum with no evidence of virilization suggest possibly safety while chest feeding, though this needs further investigation.

  60. American College of Obstetricians and Gynecologists. Health Care for transgender and gender diverse individuals: ACOG Committee Opinion, Number 823. Obstet Gynecol. 2021;137:e75.

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health Fertility, 300 Community Drive, Manhasset, NY, 11030, USA

    Petrina LaFaire & Randi H. Goldman

Authors
  1. Petrina LaFaire
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Randi H. Goldman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Petrina LaFaire.

Ethics declarations

Conflicts of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Care for the Transgender Patients

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

LaFaire, P., Goldman, R.H. Sexual and Reproductive Health for Transgender and Gender-Diverse Patients. Curr Obstet Gynecol Rep 11, 81–89 (2022). https://doi.org/10.1007/s13669-022-00333-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13669-022-00333-8

Keywords

Search

Navigation